[Clinical significance of anti-cardiolipin antibody in patients with systemic lupus erythematosus (SLE)]. 1994

K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
Second Department of Internal Medicine, Saitama Medical School, Kawagoe-city.

Anti-cardiolipin antibody (aCL) in SLE patients reacts with cardiolipin/beta 2-GP1 complex. In order to disclose clinical significance of aCL in patients with SLE, aCL was determined by newly-developed anti-CL.beta 2-GP1 kit [Yamasa] EIA in 58 patients with SLE and the relationship between clinical manifestation of SLE and the presence of aCL was examined. Anti-cardiolipin antibody was positive in 20 patients (34.5%). In 20 SLE patients with positive aCL, livedo reticularis in 7, retinal vein thrombosis in 3, thrombophlebitis in 3 and other vasculo-occlusive episodes were observed as a characteristic clinical features of positive aCL. In contrast, a SLE patient complicated by ileal perforation due to necrotizing angiitis had negative aCL. Other clinical and laboratory features associated with aCL include recurrent fetal loss and thrombocytopenia.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017153 Antibodies, Anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN. Anticardiolipin Antibodies,Anticardiolipin Autoantibodies,Anticardiolipin Autoantibody,Cardiolipin Autoantibodies,Cardiolipin Autoantibody,Anticardiolipin Antibody,Antibody, Anticardiolipin,Autoantibody, Anticardiolipin,Autoantibody, Cardiolipin

Related Publications

K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
April 1989, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
November 1988, The American journal of medicine,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
November 1988, The British journal of dermatology,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
April 2023, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
January 1995, Rheumatology international,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
December 1993, American journal of epidemiology,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
April 2024, Heliyon,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
November 1989, The American journal of medicine,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
January 2009, Reumatologia clinica,
K Aoki, and T Takeuchi, and I Itoh, and Y Takano, and T Itoh, and O Hosono, and J Koide, and T Abe
August 1978, The Journal of dermatology,
Copied contents to your clipboard!